Eupraxia Pharmaceuticals Inc. (TSX:EPRX)
Canada · Delayed Price · Currency is CAD 9.43
-0.16 (-1.67%)
Oct 14, 2026, 2:54 PM EST
Eupraxia Pharmaceuticals Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $27.02 | Buy | Maintains | $27.02 | +186.50% | Oct 9, 2026 |
| Wedbush | Wedbush | Buy Maintains $24.17 | Buy | Maintains | $24.17 | +156.34% | Oct 1, 2026 |
| Bloom Burton | Bloom Burton | Buy Maintains $19.91 | Buy | Maintains | $19.91 | +111.11% | Oct 1, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $15.64 | Buy | Reiterates | $15.64 | +65.87% | Oct 1, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $22.75 | Buy | Maintains | $22.75 | +141.26% | Sep 30, 2026 |
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Sep 30, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Reiterates $35.55 | Buy | Reiterates | $35.55 | +276.97% | Sep 24, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $24.17 | Buy | Maintains | $24.17 | +156.34% | Aug 12, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.